Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Bayer's BAY-80-6946 induces regression in tumor models

May 19, 2010

Snapshots: Recent data on denosumab for postmenopausal osteoporosis

May 19, 2010

Preclinical and clinical data on dual FXR/TGR5 agonist INT-767 disclosed by Intercept

May 19, 2010

Phase III data point to efficacy of pirfenidone in idiopathic pulmonary fibrosis

May 18, 2010

CR-2017 improves intestinal activity/tolerance in functional gut disorders patients

May 18, 2010

Phase II safety/efficacy data on anti-IP-10 antibody in subjects with active UC presented

May 18, 2010

LA-480 inhibits HGF-dependent and independent c-Met signaling in preclinical study

May 18, 2010

ArQule presents preclinical data on novel Raf kinase B and C inhibitors

May 18, 2010

Low efficacy seen with FMP2.1/AS02A malaria vaccine in children

May 18, 2010

AIN-457 evaluated in clinical studies in patients with noninfectious uveitis

May 18, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...